| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Adrenocortical carcinoma
|
Gicquel, C.
|
|
|
8 |
5 |
p. 423-427
|
article
|
| 2 |
Adrenocortical carcinoma
|
C. Gicquel
|
|
1997
|
8 |
5 |
p. 423-427
5 p.
|
article
|
| 3 |
A phase II study of raltitrexed (‘Tomudex’*) in patients with hepatocellular carcinoma
|
Rougier, P.
|
|
|
8 |
5 |
p. 500-502
|
article
|
| 4 |
A phase II study of raltitrexed (Tomudex) in patients withhepatocellular carcinoma
|
P. Rougier
|
|
1997
|
8 |
5 |
p. 500-502
5 p.
|
article
|
| 5 |
Awards, appointments
|
|
|
|
8 |
5 |
p. 411-412
|
article
|
| 6 |
Book review
|
Sessa, C.
|
|
|
8 |
5 |
p. 414
|
article
|
| 7 |
Book review
|
Bertoni, F.
|
|
|
8 |
5 |
p. 422
|
article
|
| 8 |
Cell signaling and cancer treatment
|
Corda, D.
|
|
|
8 |
5 |
p. 429-433
|
article
|
| 9 |
Cell signaling and cancer treatment
|
D. Corda
|
|
1997
|
8 |
5 |
p. 429-433
5 p.
|
article
|
| 10 |
Chemotherapy for advanced pancreatic cancer - some light at the end of the tunnel?
|
Popescu, R.A.
|
|
|
8 |
5 |
p. 415-416
|
article
|
| 11 |
Chemotherapy for advanced pancreatic cancer some light at the endof the tunnel?
|
R. A. Popescu
|
|
1997
|
8 |
5 |
p. 415-416
2 p.
|
article
|
| 12 |
Chemotherapy for symptom control in recurrent squamous cell carcinoma of the head and neck
|
Constenla, D.O.
|
|
|
8 |
5 |
p. 445-449
|
article
|
| 13 |
Chemotherapy for symptom control in recurrent squamous cell carcinoma of the head and neck
|
D. O. Constenla
|
|
1997
|
8 |
5 |
p. 445-449
5 p.
|
article
|
| 14 |
Contention over mammography in the US
|
|
|
|
8 |
5 |
p. 410-411
|
article
|
| 15 |
Contents of the next issue
|
|
|
|
8 |
5 |
p. v
|
article
|
| 16 |
Copyright
|
|
|
|
8 |
5 |
p. iii
|
article
|
| 17 |
Decrease of Interleukin-2 secretion is a new independent prognostic factor associated with poor survival in patients with small-cell lung cancer*
|
Fischer, J.R.
|
|
|
8 |
5 |
p. 457-461
|
article
|
| 18 |
Decrease of Interleukin-2 secretion is a new independent prognosticfactor associated with poor survival in patients with small-cell lungcancer
|
J. R. Fischer
|
|
1997
|
8 |
5 |
p. 457-461
5 p.
|
article
|
| 19 |
Diagnosis of HIV-related primary central nervous system lymphoma: Is there still a role for brain biopsy? A case history
|
Viale, P.
|
|
|
8 |
5 |
p. 491-496
|
article
|
| 20 |
Diagnosis of HIV-related primary central nervous system lymphoma: Isthere still a role for brain biopsy? A case history
|
P. Viale
|
|
1997
|
8 |
5 |
p. 491-496
6 p.
|
article
|
| 21 |
Does chemotherapy for head and neck cancer improve symptoms?
|
Kies, M.S.
|
|
|
8 |
5 |
p. 417-418
|
article
|
| 22 |
Does chemotherapy for head and neck cancer improve symptoms?
|
M. S. Kies
|
|
1997
|
8 |
5 |
p. 417-418
2 p.
|
article
|
| 23 |
Does surgery belong to medical history for gastric lymphomas?
|
Coiffier, B.
|
|
|
8 |
5 |
p. 419-421
|
article
|
| 24 |
Does surgery belong to medical history for gastric lymphomas?
|
B. coiffier
|
|
1997
|
8 |
5 |
p. 419-421
3 p.
|
article
|
| 25 |
Editorial Board
|
|
|
|
8 |
5 |
p. iv
|
article
|
| 26 |
Experience with independent radiological review during a topotecan trial in ovarian cancer
|
Gwythen, S.
|
|
|
8 |
5 |
p. 463-468
|
article
|
| 27 |
Experience with independent radiological review during a topotecan trialin ovarian cancer
|
S. Gwyther
|
|
1997
|
8 |
5 |
p. 463-468
6 p.
|
article
|
| 28 |
F.E. Cotter (ed): Methods in molecular medicine. Molecular diagnosis of cancer
|
F. Bertoni
|
|
1997
|
8 |
5 |
p. 422-422
1 p.
|
article
|
| 29 |
F.M. Muggia (ed): Concepts, mechanisms, andnew targets for chemotherapy
|
C. Sessa
|
|
1997
|
8 |
5 |
p. 414-414
1 p.
|
article
|
| 30 |
IBCSG comes of age
|
|
|
|
8 |
5 |
p. 409-410
|
article
|
| 31 |
Initial chemotherapy for primary resectable large-cell lymphoma of the stomach
|
Tondini, C.
|
|
|
8 |
5 |
p. 497-499
|
article
|
| 32 |
Initial chemotherapy for primary resectable large-cell lymphoma of the stomach
|
C. Tondini
|
|
1997
|
8 |
5 |
p. 497-499
3 p.
|
article
|
| 33 |
In this issue
|
|
|
|
8 |
5 |
p. v
|
article
|
| 34 |
Is acute dyspnoea a rare side effect of vinorelbine?
|
Tassinari, D.
|
|
|
8 |
5 |
p. 503-504
|
article
|
| 35 |
Is acute dyspnoea a rare side effect of vinorelbine? & Reply
|
D. Tassinari
|
|
1997
|
8 |
5 |
p. 503-504
2 p.
|
article
|
| 36 |
New look for oncology in Leuven
|
|
|
|
8 |
5 |
p. 409
|
article
|
| 37 |
New look for oncology in Leuven; IBCSG comes of age; Contention over mammography in the US; Awards, appointments; Medical oncology wins specialty status in Europe; Perhaps not everyone knows that...
|
|
|
1997
|
8 |
5 |
p. 409-413
5 p.
|
article
|
| 38 |
Paclitaxel by three-hour infusion and carboplatin in advanced carcinoma of nasopharynx and other sites of the head and neck
|
Fountzilas, G.
|
|
|
8 |
5 |
p. 451-455
|
article
|
| 39 |
Paclitaxel by three-hour infusion and carboplatin in advanced carcinomaof nasopharynx and other sites of the head and neck
|
G. Fountzilas
|
|
1997
|
8 |
5 |
p. 451-455
5 p.
|
article
|
| 40 |
Perhaps not everyone knows that…
|
|
|
|
8 |
5 |
p. 412-413
|
article
|
| 41 |
Phase I study of paclitaxel and oral etoposide in previously untreated non-small-cell and extensive small-cell lung cancer
|
Boyer, M.J.
|
|
|
8 |
5 |
p. 485-489
|
article
|
| 42 |
Phase I study of paclitaxel and oral etoposide in previously untreated non-small-cell and extensive small-cell lung cancer
|
M. J. Boyer
|
|
1997
|
8 |
5 |
p. 485-489
5 p.
|
article
|
| 43 |
Should subjects who used psoralen suntan activators be screened for melanoma?
|
Autier, P.
|
|
|
8 |
5 |
p. 435-437
|
article
|
| 44 |
Should subjects who used psoralen suntan activators be screened for melanoma?
|
P. Autier
|
|
1997
|
8 |
5 |
p. 435-437
3 p.
|
article
|
| 45 |
Small-cell carcinoma of the seminal vesicle responding to chemotherapy
|
Hoppin, E.C.
|
|
|
8 |
5 |
p. 503
|
article
|
| 46 |
Small-cell carcinoma of the seminal vesicle responding to chemotherapy
|
E. C. Hoppin
|
|
1997
|
8 |
5 |
p. 503-503
1 p.
|
article
|
| 47 |
Table of Contents
|
|
|
|
8 |
5 |
p. ii-iii
|
article
|
| 48 |
The combined evaluation ofp53 accumulation and of Ki-67 (MIBI) labelling index provides independent information on overall survival of ovarian carcinoma patients
|
Viale, G.
|
|
|
8 |
5 |
p. 469-476
|
article
|
| 49 |
The combined evaluation of p53 accumulation and of Ki-67 (MIB1) labellingindex provides independent information on overall survival of ovariancarcinoma patients
|
G. Viale
|
|
1997
|
8 |
5 |
p. 469-476
8 p.
|
article
|
| 50 |
This letter was referred to the author who responds as follows
|
Raderer, M.
|
|
|
8 |
5 |
p. 504
|
article
|
| 51 |
Treatment of advanced pancreatic carcinoma with a combination of protracted infusional 5-fluorouracil and weekly carboplatin: A Mid-Atlantic Oncology Program study
|
Auerbach, M.
|
|
|
8 |
5 |
p. 439-444
|
article
|
| 52 |
Treatment of advanced pancreatic carcinoma with a combination ofprotracted infusional 5-fluorouracil and weekly carboplatin: A Mid-AtlanticOncology Program study
|
M. Auerbach
|
|
1997
|
8 |
5 |
p. 439-444
6 p.
|
article
|
| 53 |
Treatment of men with metastatic non-seminomatous germ cell tumours with cyclical POMB/ACE chemotherapy
|
Bower, M.
|
|
|
8 |
5 |
p. 477-483
|
article
|
| 54 |
Treatment of men with metastatic non-seminomatous germ cell tumours with cyclical POMB/ACE chemotherapy
|
M. Bower
|
|
1997
|
8 |
5 |
p. 477-483
7 p.
|
article
|
Journal description